Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Lark Health names a new Chief Growth Officer to scale GLP-1 cost containment and care offerings | ||
By: PR Newswire Association LLC. - 12 Apr 2024 | Back to overview list |
|
MOUNTAIN VIEW, Calif., April 12, 2024 /PRNewswire/ -- As employers, payers and PBMs struggle to curb the budget pressures that GLP-1 medication demand has inflicted upon the healthcare industry, Lark Health has brought on a new Chief Growth Officer, Darren Eckberg, to lead Lark's national expansion of its AI-guided, GLP-1 cost containment technology. Lark Health is a leading provider of weight management and cardiometabolic care for employers and health plans— serving nearly 2.5 million patients and more than 2000 employers. This expansion is a natural evolution for Lark's infinitely scalable, tech-first care programs. Lark names a new Chief Growth Officer, Darren Eckberg, to lead the expansion of its AI, GLP-1 cost containment programs. Eckberg brings over 20 years of experience working at PBMs and healthcare organizations— having held executive roles at IngenioRx/Anthem, EnvisionRx/Rite Aid, Prime Therapeutics and Express Scripts. "I'm honored to be joining the Lark team and am thrilled to help millions of Americans struggling with a chronic condition. As one of the pioneers in AI health tech, Lark's spirit for innovation is complemented by a dedication to clinical excellence and being a responsible partner for our clients. The impacts of GLP-1 medications affect the entire healthcare system and a thoughtfully designed end-to-end offering can benefit everyone from the individual member struggling with obesity to the employer struggling with the skyrocketing GLP-1 costs," says Eckberg. Lark's current GLP-1 offerings include comprehensive services designed to achieve a 77% reduction in GLP-1 costs, while simultaneously optimizing population health outcomes. Healthy Weight: Delivers personalized, virtual lifestyle coaching for members as an alternative or prerequisite to GLP-1s that helps build lasting lifestyle change, leading to improvements in weight, activity, and associated diseases. GLP-1 Companion: Offers unlimited patient support for eligible members on GLP-1s while encouraging medication success with coaching on medication adherence, side effect mitigation and monitoring, and lifestyle modification. Weight Maintenance: Supports participants who have achieved their clinical outcomes and are looking to maintain weight loss long-term, as well as those weaning off of a GLP-1 medication. Clinician-Guided Step Therapy: Provides qualified members with access to end-to-end clinician-guided management, telehealth visits with remote patient monitoring, prescription management, insurance navigation, prior authorization obtainment and more. "We are so proud to have an executive of Darren's caliber help us drive towards our mission, which is to provide infinitely scalable, compassionate care to anyone in need. GLP-1s are an incredible tool in this toolbox, but it has to be affordable and targeted to the right populations who need the help most. As a tech and AI-centric company, we are proud that our technology is being used to bend the drug cost utilization curve at scale," says CEO and Co-Founder, Julia Hu. About Lark Health? CONTACT: Andrew Norris, andrew.norris@lark.com View original content to download multimedia:https://www.prnewswire.com/news-releases/lark-health-names-a-new-chief-growth-officer-to-scale-glp-1-cost-containment-and-care-offerings-302114986.html SOURCE Lark Health |
||
|
||
Copyright 2024 PR Newswire Association LLC. | Back to overview list |